NEW YORK, Nov. 2, 2023 /PRNewswire/ — The Blood Screening Market size is expected to grow by USD 1.17 billion, accelerating at a CAGR of 7.42% during the forecast period, according to Technavio market research analysis. The report analyzes the market’s competitive landscape and offers information on several market companies, including Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Dr Lal PathLabs Ltd., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Harley Street Health Checks UK Ltd., Hemogenomics Pvt. Ltd., Laboratory Corp. of America Holdings, Mankind Pharma Ltd., Metropolis Healthcare Ltd., QuidelOrtho Corp., Siemens Healthineers AG, Syantra Inc., Thermo Fisher Scientific Inc., and Vijaya Diagnostic Centre Ltd. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Technavio has announced its latest market research report titled Global Blood Screening Market 2023-2027
Blood Screening Market 2023 – 2027: Company Profile:
BCAL Diagnostics Ltd: The company offers blood screening tests such as the BCAL test which is a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring.
To gain access to more vendor profiles available with Technavio, buy the report
Blood Screening Market 2023 – 2027: Regional Analysis
North America is expected to contribute 42% to the global blood screening market’s growth during the forecast period. One significant factor driving the growth of the global blood screening market in North America is the increasing recognition of the importance of blood screening in ensuring the safety of the blood supply and preventing the transmission of infectious diseases. This process involves the testing of donated blood for various pathogens and health conditions before it’s used for medical purposes. Advancements in medical technology, increased awareness of blood safety, regulatory requirements, and healthcare demands are all boosting the demand for blood screening in North America. Consequently, these factors are expected to foster market growth in the region between 2022 – 2027.
Blood Screening Market 2023 – 2027: Segmentation Analysis
The market is segmented by Component (Reagents and kits, Instruments, and Software and services), End-user (Blood bank and Hospitals), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The reagents and kits segment is expected to witness substantial growth during the forecast period. This segment plays a significant role in laboratory testing procedures, particularly in screening donated blood for infectious diseases to ensure its safety for transfusion. Reagents are substances or compounds employed in laboratory tests to initiate a chemical reaction with specific elements within a sample, such as blood.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
Blood Screening Market 2023 – 2027: Driver & Trend:
Driver
Blood screening ensures a safe blood supply by detecting infections and diseases.
Growing demand for blood transfusions emphasizes efficient blood screening processes.
Advancements in medical treatments, surgeries, organ transplants, and trauma care drive the need for safe blood products.
Increasing prevalence of chronic diseases and medical conditions necessitating surgeries or treatments fuels the demand for comprehensive blood screening, positively impacting market growth.
Trend – A key factor shaping the blood screening market growth is the automation of the blood screening process.
Identify key trends, drivers, and challenges in the market. Download the sample report to gain access to this information
Related Reports:
Molecular Diagnostics Market: The Molecular Diagnostics Market size is estimated to grow at a CAGR of 5.96% between 2022 and 2027. The market size is forecast to increase by USD 7,722.71 million.
Blood Market: The global blood market report size is expected to increase by USD 2,195.69 million from 2022 to 2027 and market growth momentum is estimated to grow at a CAGR of 5.31%.
TOC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Component
Market Segmentation by End-User
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio